Interim FDA classifications for nominated bulk drug substances. Category 1 substances may be used in compounding while under evaluation; Category 2 substances have identified safety concerns and may not; Category 3 covers substances nominated without adequate supporting information. Removal from Category 2 is not an approval.
Interim FDA classifications for nominated bulk drug substances. Category 1 substances may be used in compounding while under evaluation; Category 2 substances have identified safety concerns and may not; Category 3 covers substances nominated without adequate supporting information. Removal from Category 2 is not an approval.
Stay current
Free. We email when results are in, and nothing else.
Powered by MailerLite. No spam. Unsubscribe anytime.